Clinical trial
Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV…
NCT00158704 · Gilead Sciences, Industry · Terminated
Key facts
| NCT number | NCT00158704 |
|---|---|
| Title | Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection. |
| Official title | An Open-Label, Continued Access Study of Adefovir Dipivoxil for Patients With Chronic HBV Infection Who Have Completed a Gilead-Sponsored Study of Adefovir Dipivoxil. |
| Lead sponsor | Gilead Sciences, Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Hepatitis B |
| Intervention type | Drug |
| Interventions | Hepsera |
| Enrollment | 400 |
| Start date | Jan 1, 2002 |
| Completion | Jan 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Mar 8, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: